Mark A. Miles

6.4k total citations · 1 hit paper
39 papers, 4.6k citations indexed

About

Mark A. Miles is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Mark A. Miles has authored 39 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Immunology and 10 papers in Epidemiology. Recurrent topics in Mark A. Miles's work include Cell death mechanisms and regulation (10 papers), DNA Repair Mechanisms (7 papers) and Respiratory viral infections research (5 papers). Mark A. Miles is often cited by papers focused on Cell death mechanisms and regulation (10 papers), DNA Repair Mechanisms (7 papers) and Respiratory viral infections research (5 papers). Mark A. Miles collaborates with scholars based in Australia, Ireland and United States. Mark A. Miles's co-authors include Robert F. Simons, Roger S. Ulrich, Christine J. Hawkins, Frances K. Graham, Xiaoping Xiong, Raymond K. Mulhern, Winfred C. Wang, R. Grant Steen, Kathleen J. Helton and Thomas E. Merchant and has published in prestigious journals such as Scientific Reports, Biochemical Journal and International Journal of Molecular Sciences.

In The Last Decade

Mark A. Miles

37 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stress recovery during exposure to natural and urban environments

1991 3.9k citations Mark A. Miles et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark A. Miles Australia	14	3.3k	982	910	623	621	39	4.6k
Gregory N. Bratman United States	23	3.4k 1.0×	811 0.8×	1.2k 1.3×	961 1.5×	687 1.1×	53	5.1k
Patrik Grahn Sweden	33	4.1k 1.2×	1.2k 1.2×	722 0.8×	1.2k 1.9×	1.0k 1.7×	84	5.0k
Jo Barton United Kingdom	30	3.2k 1.0×	792 0.8×	1.3k 1.4×	398 0.6×	507 0.8×	60	5.0k
Peter Aspinall United Kingdom	31	2.5k 0.8×	701 0.7×	662 0.7×	753 1.2×	461 0.7×	83	4.1k
Rita Berto Italy	16	2.1k 0.6×	581 0.6×	682 0.7×	412 0.7×	392 0.6×	32	2.6k
Igor Knez Sweden	32	2.0k 0.6×	679 0.7×	859 0.9×	1.1k 1.8×	968 1.6×	112	4.5k
Jenny Roe United Kingdom	25	2.3k 0.7×	686 0.7×	503 0.6×	644 1.0×	502 0.8×	52	3.1k
Takahide Kagawa Japan	32	5.5k 1.7×	1.1k 1.1×	1.4k 1.5×	958 1.5×	970 1.6×	65	6.8k
Ulrika K. Stigsdotter Denmark	30	4.0k 1.2×	958 1.0×	627 0.7×	1.4k 2.3×	994 1.6×	55	4.6k
Angel M. Dzhambov Bulgaria	31	3.9k 1.2×	2.4k 2.4×	290 0.3×	931 1.5×	1.3k 2.1×	105	4.9k

Countries citing papers authored by Mark A. Miles

Since Specialization

Citations

This map shows the geographic impact of Mark A. Miles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Miles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Miles more than expected).

Fields of papers citing papers by Mark A. Miles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Miles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Miles. The network helps show where Mark A. Miles may publish in the future.

Co-authorship network of co-authors of Mark A. Miles

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Miles. A scholar is included among the top collaborators of Mark A. Miles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Miles. Mark A. Miles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Best, Giles, Mark P. Ward, Stavros Selemidis, et al.. (2025). Metabolic reprogramming, malignant transformation and metastasis: Lessons from chronic lymphocytic leukaemia and prostate cancer. Cancer Letters. 611. 217441–217441. 3 indexed citations

Liong, Stella, et al.. (2024). Early-Life Respiratory Syncytial Virus (RSV) Infection Triggers Immunological Changes in Gut-Associated Lymphoid Tissues in a Sex-Dependent Manner in Adulthood. Cells. 13(20). 1728–1728. 2 indexed citations

Miles, Mark A., Stella Liong, Hao Wang, et al.. (2024). TLR7 Promotes Acute Inflammatory-Driven Lung Dysfunction in Influenza-Infected Mice but Prevents Late Airway Hyperresponsiveness. International Journal of Molecular Sciences. 25(24). 13699–13699. 3 indexed citations

Miles, Mark A., Raymond Luong, Eunice E. To, et al.. (2024). TLR9 Monotherapy in Immune-Competent Mice Suppresses Orthotopic Prostate Tumor Development. Cells. 13(1). 97–97. 2 indexed citations

Brooks, Robert D., Mark A. Miles, Zivile Useckaite, et al.. (2024). Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system. Cancer Letters. 585. 216639–216639. 8 indexed citations

Liong, Stella, Mark A. Miles, Kurt Brassington, et al.. (2024). Low dose aspirin prevents endothelial dysfunction in the aorta and foetal loss in pregnant mice infected with influenza A virus. Frontiers in Immunology. 15. 1378610–1378610. 2 indexed citations

Liong, Stella, et al.. (2023). Influenza A virus infection during pregnancy causes immunological changes in gut-associated lymphoid tissues of offspring mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 325(3). G230–G238. 4 indexed citations

Miles, Mark A., Stella Liong, Robert D. Brooks, et al.. (2023). TLR7 promotes chronic airway disease in RSV-infected mice. Frontiers in Immunology. 14. 1240552–1240552. 7 indexed citations

Liong, Stella, Eunice E. To, Raymond Luong, et al.. (2022). Influenza A virus elicits peri-vascular adipose tissue inflammation and vascular dysfunction of the aorta in pregnant mice. PLoS Pathogens. 18(8). e1010703–e1010703. 5 indexed citations

10.

Harris, Michael A., et al.. (2021). The smac mimetic LCL161 targets established pulmonary osteosarcoma metastases in mice. Clinical & Experimental Metastasis. 38(5). 441–449. 6 indexed citations

11.

Harris, Michael A., Mark A. Miles, Smitha R. Georgy, et al.. (2020). The Proteasome Inhibitor Ixazomib Inhibits the Formation and Growth of Pulmonary and Abdominal Osteosarcoma Metastases in Mice. Cancers. 12(5). 1207–1207. 13 indexed citations

12.

Harris, Michael A., et al.. (2020). Transient NK Cell Depletion Facilitates Pulmonary Osteosarcoma Metastases After Intravenous Inoculation in Athymic Mice. Journal of Adolescent and Young Adult Oncology. 9(6). 667–671. 8 indexed citations

13.

Miles, Mark A. & Christine J. Hawkins. (2020). In vitro analysis reveals necroptotic signaling does not provoke DNA damage or HPRT mutations. Cell Death and Disease. 11(8). 680–680. 2 indexed citations

14.

Miles, Mark A., Sarah Caruso, Amy A. Baxter, Ivan K. H. Poon, & Christine J. Hawkins. (2020). Smac mimetics can provoke lytic cell death that is neither apoptotic nor necroptotic. APOPTOSIS. 25(7-8). 500–518. 9 indexed citations

15.

Miles, Mark A., Michael A. Harris, & Christine J. Hawkins. (2019). Proteasome inhibitors trigger mutations via activation of caspases and CAD, but mutagenesis provoked by the HDAC inhibitors vorinostat and romidepsin is caspase/CAD-independent. APOPTOSIS. 24(5-6). 404–413. 7 indexed citations

16.

Miles, Mark A. & Christine J. Hawkins. (2017). Executioner caspases and CAD are essential for mutagenesis induced by TRAIL or vincristine. Cell Death and Disease. 8(10). e3062–e3062. 30 indexed citations

17.

Miles, Mark A., et al.. (2016). TRAIL causes deletions at the HPRT and TK1 loci of clonogenically competent cells. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 787. 15–31. 6 indexed citations

18.

Merchant, Thomas E., et al.. (2002). Acute effects of irradiation on cognition: changes in attention on a computerized continuous performance test during radiotherapy in pediatric patients with localized primary brain tumors. International Journal of Radiation Oncology*Biology*Physics. 53(5). 1271–1278. 61 indexed citations

19.

Steen, R. Grant, et al.. (2002). Kindergarten Readiness Skills in Children With Sickle Cell Disease: Evidence of Early Neurocognitive Damage?. Journal of Child Neurology. 17(2). 111–116. 30 indexed citations

20.

Miles, Mark A., et al.. (1991). Cognitive Remediation in Pediatric Head Injury: A Case Study. Journal of Pediatric Psychology. 16(5). 611–627. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact